Close Menu

In an editorial, Nature announces that they will be introducing a creative commons license for the reuse of papers reporting full genome sequences. Under this license, non-commercial publishers may reuse the pdf and html versions of the article and other users may copy, distribute, and/or adapt the paper for non-commercial uses. This continues, the editors write, "[Nature's] drive to make papers as accessible as possible."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.

The New York Times reports that a new viral variant of concern has been identified in New York City.

In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.